Discover open access scientific publications

Search, annotate, share and cite publications

Publications by L. Krasnova

Clinical and Economic Analysis of Effectiveness of Everolimus in the Treatment of HR+, HER2- Advanced Breast Cancer in Russia

Value in Health

English

PSY48 Health-Related Quality of Life in Russian Patients With Inhibitor Hemophilia

English

Related publications

Use of Novel Combination Therapies in the Treatment of Advanced HR+/HER2− Breast Cancer

Journal of the National Comprehensive Cancer Network : JNCCN

Medicine

Oncology

2018

English

Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer

Geburtshilfe und Frauenheilkunde

English

Pharmacoeconomic Analysis of Using Cyclin-Dependent Kinase 4 and 6 Inhibitors in the First Line Treatment of HR-positive HER2-negative Advanced Breast Cancer

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

2020

English

Pcn337 - Hr+/Her2− Advanced Breast Cancer Treatment, Disease Progression, and Survival in Argentina, Brazil, Chile, Colombia, and Mexico

English

Everolimus-Based Therapy Versus Chemotherapy Among Patients With HR+/HER2− Metastatic Breast Cancer: Comparative Effectiveness From a Chart Review Study

International Journal of Breast Cancer

English

Palbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast Cancer

English

Real-World Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National Cancer Database Analysis

Scientific Reports

Multidisciplinary

2019

English

Development and Clinical Effectiveness of Antiandrogens in the Treatment of Advanced Prostate Cancer

Medical Council

2016

English

Retrospective Analysis of HER2 Therapy Interruption in Patients Responding to the Treatment in Metastatic HER2+ Breast Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by L. Krasnova

Clinical and Economic Analysis of Effectiveness of Everolimus in the Treatment of HR+, HER2- Advanced Breast Cancer in Russia

PSY48 Health-Related Quality of Life in Russian Patients With Inhibitor Hemophilia

Related publications

Use of Novel Combination Therapies in the Treatment of Advanced HR+/HER2− Breast Cancer

Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer

Pharmacoeconomic Analysis of Using Cyclin-Dependent Kinase 4 and 6 Inhibitors in the First Line Treatment of HR-positive HER2-negative Advanced Breast Cancer

Pcn337 - Hr+/Her2− Advanced Breast Cancer Treatment, Disease Progression, and Survival in Argentina, Brazil, Chile, Colombia, and Mexico

Everolimus-Based Therapy Versus Chemotherapy Among Patients With HR+/HER2− Metastatic Breast Cancer: Comparative Effectiveness From a Chart Review Study

Palbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast Cancer

Real-World Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National Cancer Database Analysis

Development and Clinical Effectiveness of Antiandrogens in the Treatment of Advanced Prostate Cancer

Retrospective Analysis of HER2 Therapy Interruption in Patients Responding to the Treatment in Metastatic HER2+ Breast Cancer